Skip to search formSkip to main contentSkip to account menu

Iron Chelating Activity [MoA]

Known as: Iron Chelating Activity, Iron Chelator 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
Background Following a clinical evaluation of deferasirox (Exjade®) it was concluded that, in addition to baseline body iron… 
Highly Cited
2010
Highly Cited
2010
The biological mode of action of artemisinin, a potent antimalarial, has long been controversial. Previously we established a… 
Highly Cited
2008
Highly Cited
2008
Background: Many diseases are associated with oxidative stress caused by free radicals. Current research is directed towards… 
Highly Cited
2004
Highly Cited
2004
Abstract: In Parkinson's disease (PD) and its neurotoxin‐induced models, 6‐hydroxydopamine (6‐OHDA) and N‐methyl‐4‐phenyl‐1,2,3,6… 
Highly Cited
2003
Highly Cited
2003
The identification of a safe, orally active iron chelator is critically important for the prevention of morbidity and early death… 
Highly Cited
2003
Highly Cited
2003
Heme oxygenase 1 (HO-1) catalyzes heme breakdown, eventually releasing iron, carbon monoxide, and bilirubin IXα. HO-1 is induced… 
Highly Cited
1992
Highly Cited
1992
We have previously shown that cytokines and postischemic cardiac lymph induce expression of intercellular adhesion molecule-1… 
Highly Cited
1988
Highly Cited
1988
Adriamycin is an anthracycline drug with a wide spectrum of clinical antineoplastic activity. However, the usefulness of the drug… 
Highly Cited
1984
Highly Cited
1984
Phenanthroline, a strong iron chelator, prevents both the formation of DNA single-strand breaks and the killing of mouse cells…